Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil

PURPOSE: Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death worldwide. Platinum agents and fluoropyrimidines are the main compounds used in the first-line setting for advanced GC. Given the activity of fluorouracil (FU) bolus, the PFL protocol, a chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Rafael C., Abreu, Pedro D.P., Monteiro, Mariana R., Stramosk, Ana Paula, Garces, Alvaro Henrique I., Melo, Andreia Cristina, Graudenz, Marcia S., Andrade, Carlos Jose C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426504/
https://www.ncbi.nlm.nih.gov/pubmed/30668271
http://dx.doi.org/10.1200/JGO.18.00176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426504/
https://www.ncbi.nlm.nih.gov/pubmed/30668271
http://dx.doi.org/10.1200/JGO.18.00176

Ejemplares similares